Spanish government will implement new rules for crypto ads

The CNMV will require advertisers to report ten days before running ads targeting 100,000 people or more.

2736 Total views

35 Total shares

Spanish government will implement new rules for crypto ads

Spanish financial regulator Comisión Nacional del Mercado de Valores, or CNMV, announced new regulations for crypto-asset investments advertising. According to the new circular that will take effect on February 17, 2022, crypto ads must be “clear, balanced and fair” while also providing sufficient information on the risks involved when investing in crypto.

The new rules also require advertisers targeting 100,000 people or more to inform the regulator 10 days in advance. After the initial report, the remaining ad activities will be supervised by the CNMV, but will not require advanced reporting. 

The CNMV also made it clear that influencers are covered by the new advertising regulations. The rules apply to crypto service providers running ads on their own or through third-party ad providers like crypto influencers. 

Aside from these rules, the CNMV also requires crypto ads to include a snippet informing the audience that crypto investments are not regulated and a warning that the full amount invested may be lost. Lastly, the ads must also present links to more information. 

While the regulator is targeting advertisements, the issuance of assets and other crypto-related services are not covered by the new rules. 

Related: London assembly member calls for ban on crypto ads in trains and buses

The United Kingdom’s Advertising Standards Authority, or ASA, is also cracking down on crypto ads. Last year, the advertising regulator took down ads made by crypto firms Coinbase, Kraken, eToro and others for ad violations. More recently, ASA banned two mobile app ads by Crypto.com.

Meanwhile, the Monetary Authority of Singapore issued crypto ad restrictions as well. The guidelines prohibit digital payment token, or DPT, providers from advertising their products in public spaces such as public transportation public websites, social media, broadcast and print media. However, DPT providers can still advertise their products and services on their native websites and mobile applications.

Note: This article have been indexed to our site. We do not claim legitimacy, ownership or copyright of any of the content above. To see the article at original source Click Here

Related Posts
Success depends on adaptability to change thumbnail

Success depends on adaptability to change

Найден Костадинов е новият лидер на бизнес линията на EY за данъчни и правни услуги в девет държави в Югоизточна Европа – България, Гърция, Кипър, Румъния, Малта, Молдова, Северна Македония, Албания и Косово. Присъединява се към EY през 2001 г. като част от отдела за одит услуги, после става директор в отдел „Стратегия и сделки“,…
Read More

Stocks, Futures Begin New Quarter With Declines: Markets Wrap

This advertisement has not loaded yet, but your article continues below. Author of the article: Bloomberg News Rita Nazareth and Vildana Hajric Article content (Bloomberg) — Stocks climbed as prospects for a pickup in growth outweighed concern over inflation pressures at a time when the Federal Reserve is getting ready to wind down its pandemic-era…
Read More
U.S. Charges Another Suspect in Haitian President's Killing thumbnail

U.S. Charges Another Suspect in Haitian President’s Killing

U.S. prosecutors in Miami have detained and charged a second suspect in connection with the July assassination of Haitian President Jovenel Moïse, highlighting progress by American investigators even as the six-month probe in Haiti remains stalled. Haitian businessman Rodolphe Jaar appeared in a Miami federal court Thursday on charges he provided weapons, ammunition and housing to…
Read More
Samsung Group in talks to buy U.S. drugmaker Biogen thumbnail

Samsung Group in talks to buy U.S. drugmaker Biogen

Please try another search EconomyDec 30, 2021 11:31AM ET © Reuters. FILE PHOTO: Employees of Samsung Group work at the company's headquarters in Seoul April 22, 2008. REUTERS/Jo Yong-Hak (Reuters) - Samsung (KS:) BioLogics on Thursday denied a media report that said the South Korean firm was in talks to buy U.S. drugmaker Biogen Inc…
Read More
Index Of News